Quarterly Result27 May 2026, 08:26 am
Morepen Labs Q4 Net Profit Rises 69% to ₹20 Cr
AI Summary
Morepen Laboratories Ltd reported a 69% YoY increase in net profit to ₹20 crore for Q4 FY26, with gross revenue up 22% YoY to ₹472 crore. The growth was driven by export momentum and expansion in the Medical Devices business. The board has proposed a 10% dividend for FY26. Commercial production has commenced under a long-duration CDMO program. Capacity expansion is underway from ~500 KL toward ~800 KL. FY26 standalone gross revenue crossed ₹1,700 Cr, up 8%.
Key Highlights
- Q4 FY26 net profit increased 69% YoY to ₹20 Cr.
- Q4 FY26 gross revenue grew 22% YoY to ₹472 Cr.
- Board proposes a 10% dividend for FY26.
- Commercial production started under long-duration manufacturing program.
- Medical Devices business grew 31% in Q4 FY26.
Price Impact
More from MOREPENLAB